Enanta Pharmaceuticals
ENTA
#7678
Rank
HK$2.90 B
Marketcap
HK$100.64
Share price
-1.53%
Change (1 day)
156.98%
Change (1 year)

Market capitalization of Enanta Pharmaceuticals (ENTA)

Market cap: HK$2.90 Billion

As of January 2026 Enanta Pharmaceuticals has a market cap of HK$2.90 Billion. This makes Enanta Pharmaceuticals the world's 7678th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Enanta Pharmaceuticals from 2013 to 2026

End of year Market Cap

Year Marketcap Change
2026HK$2.90 B-23.23%
2025HK$3.78 B282.65%
2024HK$0.98 B-36.1%
2023HK$1.54 B-79.53%
2022HK$7.55 B-36.78%
2021HK$11.95 B82.46%
2020HK$6.55 B-31.25%
2019HK$9.53 B-11.58%
2018HK$10.77 B22.94%
2017HK$8.76 B77.28%
2016HK$4.94 B2.83%
2015HK$4.81 B-34.48%
2014HK$7.34 B93.17%
2013HK$3.80 B

End of Day market cap according to different sources

On Jan 12th, 2026 the market cap of Enanta Pharmaceuticals was reported to be:

HK$2.90 Billion
by Nasdaq info icon info icon
HK$2.90 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
AbbVie
ABBV
HK$3.031 T 104,268.87%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
HK$3.939 T 135,502.65%๐Ÿ‡บ๐Ÿ‡ธ USA
Vertex Pharmaceuticals
VRTX
HK$920.61 B 31,592.39%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
HK$2.126 T 73,094.08%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
HK$885.08 B 30,369.41%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
HK$2.121 T 72,930.41%๐Ÿ‡จ๐Ÿ‡ญ Switzerland